Literature DB >> 7874075

Evidence for the role of glycoprotein G of respiratory syncytial virus in binding of Neisseria meningitidis to HEp-2 cells.

M W Raza1, C C Blackwell, M M Ogilvie, A T Saadi, J Stewart, R A Elton, D M Weir.   

Abstract

Viral glycoproteins G and F are expressed on the surface of cells infected with respiratory syncytial virus (RSV). We investigated the role of these proteins in the previously reported enhanced binding of Neisseria meningitidis to RSV-infected HEp-2 cells. Virus particles attached to bacteria were detected by immunofluorescence with flow cytometry. Binding of FITC-labelled bacteria to RSV-infected cells was significantly inhibited by monoclonal antibody against glycoprotein G. Unlabelled bacteria interfered with binding of the anti-G monoclonal antibody to these cells. These interactions were not found with a monoclonal antibody against glycoprotein F. We propose that glycoprotein G of RSV expressed on the surface of infected cells might act as an additional receptor for meningococci.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874075     DOI: 10.1111/j.1574-695X.1994.tb00007.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  3 in total

1.  Rhinovirus disrupts the barrier function of polarized airway epithelial cells.

Authors:  Umadevi Sajjan; Qiong Wang; Ying Zhao; Dieter C Gruenert; Marc B Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

2.  Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults.

Authors:  Patricia Stutzmann Meier; Nadja Heiniger; Rolf Troller; Christoph Aebi
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

3.  Acute phase protein changes in calves during an outbreak of respiratory disease caused by bovine respiratory syncytial virus.

Authors:  Toomas Orro; Tarja Pohjanvirta; Ulla Rikula; Anita Huovilainen; Sakari Alasuutari; Liisa Sihvonen; Sinikka Pelkonen; Timo Soveri
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2009-11-07       Impact factor: 2.268

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.